| Clotting Genetic Variants, Hormones, and Venous Thrombosis (NCT00094185) | University of Washington | 2004-05-01 |
| ARIXTRA Local Study For Registration In China. (NCT00328939) | GlaxoSmithKline | 2004-05-01 |
| A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery (NCT00260988) | Ottawa Hospital Research Institute | 2003-10-01 |
| OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction (NCT00064428) | GlaxoSmithKline | 2003-08-01 |
| Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease (NCT00071032) | Rutgers, The State University of New Jersey | 2003-07-01 |
| Michelangelo - Oasis 5 (NCT00139815) | GlaxoSmithKline | 2003-04-01 |
| Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study (NCT00655122) | Pfizer | 2003-04-01 |
| ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial (NCT00839826) | Bayer | 2002-12-01 |
| Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer (NCT00031837) | Gary Morrow | 2002-10-01 |
| Epidemiology of Venous Thromboembolism (NCT00041457) | Brigham and Women's Hospital | 2002-07-01 |
| 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China (NCT00799968) | Beijing Chao Yang Hospital | 2002-06-01 |
| Nadroparin for the Initial Treatment of Pulmonary Thromboembolism (NCT00796692) | Beijing Chao Yang Hospital | 2002-06-01 |
| A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO). (NCT00038961) | GlaxoSmithKline | 2001-11-01 |
| Risk Factors for Venous Thromboembolism in the Community (NCT00011180) | Mayo Clinic | 2001-04-01 |
| Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer (NCT00014352) | Memorial Sloan Kettering Cancer Center | 2000-09-01 |
| Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00020189) | National Cancer Institute (NCI) | 2000-06-01 |
| Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters (NCT00024297) | Cancer Research Campaign Clinical Trials Centre | 1999-10-01 |
| Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care (NCT00205400) | University of Wisconsin, Madison | 1999-08-01 |
| Prevention of Recurrent Venous Thromboembolism (PREVENT) (NCT00000614) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-09-01 |
| Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin (NCT00203658) | University of Calgary | 1997-04-01 |
| Heparin or Enoxaparin in Patients With Cancer (NCT00004875) | Northwestern University | 1996-07-01 |
| Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) (NCT00203580) | University of Calgary | 1994-12-01 |